Rivaara Labs raises Rs 60 Crores in funding led by Amicus Capital & Kotak

Rivaara Labs has received Rs 60 Crores from Amicus Capital and Kotak Investment. The new funds will be used to speed the development of test kits, expand its lab network, and scale up the scientific sales force

Rivaara Labs raises Rs 60 Crores in funding led by Amicus Capital & Kotak

Rivaara Labs, the Mumbai based molecular diagnostics development company, has received Rs 60 Crores as the first institutional round from Amicus Capital and Kotak Investment. Rivaara is a vertically integrated molecular diagnostics firm launched by Daftary, a former Bharat Serums & Vaccines promoter in 2019. 

The new funds will be used to speed the development and commercialization of unique test kits, modernize production facilities, expand its lab network, and scale up the scientific sales force as well as technical expertise across India. 

Rivaara plans to add another 48 centers to its network of 12 laboratories across the country to shorten the turnaround time for patients. Also hopes to offer the kits to other diagnostics businesses and expand into international markets. 

The company worked with European research laboratories to create PCR (polymerase chain reaction) test kits. According to the research group, the tests are especially intended for identifying viruses common in India, resulting in early and successful treatments to save lives. 

According to an announcement, the tests will help prevent antibiotic overuse, which has contributed to the rising problem of antibiotic-resistant bacteria. Through its own molecular diagnostic lab network, it will first offer testing for respiratory disorders, sepsis, tuberculosis (TB), anti-microbial resistance, and other ailments. 

Dhiraj Rajendran, executive director, Kotak Investment Advisors, noted that advances in molecular diagnostics over the last few years have opened up possibilities for faster and more accurate ways to detect pathogens at affordable price points. “Adoption of some of these advances such as RT-PCR tests was witnessed during the response to the Covid-19 pandemic.” 

Daftary stated that “The vision for Rivaara is to positively impact patient care by addressing gaps in widespread adoption of molecular diagnostics through a scientific sales force to create the right awareness, presence of local labs for faster processing of samples and international quality kits at affordable prices. Amicus and Kotak have an in-depth understanding of the healthcare sector and are aligned with our vision,” 

 

Edited By:

Contributed By:

Tags : #fundingalert #rivaara #molecular #diagnostics #laboratories #RTPCR #sepsis #tuberculosis #pathology #medicine #microbiology #doctor #medicircle #smitakumar

About the Author


Rajeev Pillai

Rajeev Pillai has accumulated extensive experience in the Electronics and Telecom Service Industry with global companies in the Middle East. Being a continuous learner with a lifelong passion for writing, Rajeev writes on topics such as Healthcare, Finance, Travel and Technology.

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Empowering Consumers with Nutritional Information: FSSAI's New Labeling GuidelinesJuly 12, 2024
Innovative Migraine Research Uncovers Key Triggers and Pathways for PainJuly 12, 2024
Alarming Rise in Death's Due to HIV Among Students in Tripura: Urgent Need for ActionJuly 12, 2024
Amrita Vishwa Vidyapeetham is All Set to Produce Netravaad, an Innovative Technology for Speech Impairment July 11, 2024
Twice-Yearly Injection Shows 100% HIV Protection in Young WomenJuly 11, 2024
AIMS (Asian Hospital) Doctors Restore Disfigured Face of Road Accident VictimJuly 10, 2024
Will #PutPeopleFirst mantra drive HIV responses?July 10, 2024
Shiprocket and Snowflake AI Data Cloud to empower 1.5 lakh merchants of BHARAT to scale their data infrastructureJuly 10, 2024
Dr. Shilpa Vora, Marico expert shares tips on how you can safeguard your baby’s skin during the monsoon seasonJuly 10, 2024
Pre Budget 2024 (Ms. Deepshikha Sharma- CEO of Sharp Sight Eye Hospital) July 10, 2024
Rate of global warming caused by humans at an all-time high - research led by University of LeedsJuly 09, 2024
Dengue during Monsoon Season and Neurological Complications Associated with DengueJuly 09, 2024
Yodda Elder Care Renews Partnership with Medulance for Emergency ServicesJuly 09, 2024
Budget Expectation Quote- Dr. Sanjeev Singh, Medical Director, Amrita Hospital, FaridabadJuly 08, 2024
Honourable Justice R. Mahadevan, Chief Justice of Madras High Court, Chennai Inaugurates IIRSI 2024, India's Premier Convention on Eye SurgeryJuly 06, 2024
The Impact of Architecture on Academic Performance: How Exam Hall Design Affects Student SuccessJuly 06, 2024
Teen Dies from Brain-Eating Amoeba in Kerala: Fatal Naegleria fowleri Infections SurgeJuly 05, 2024
Chemotherapy Drug Linked to Long-Term Hearing Loss in Cancer SurvivorsJuly 05, 2024
Qatar Airways Chooses Çelebi India as Ground Handler for New Doha-Goa FlightsJuly 04, 2024
Zika Virus Alert in Maharashtra: Government's Proactive Steps for Public SafetyJuly 04, 2024